
Junicef-S 250mg/125mg Injection
Marketer
Junifer Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Junicef-S 250mg/125mg Injection
Cefixime and Sulbactam injection, 250mg/125mg, is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance; missed doses should be avoided, and the prescribed course completed regardless of symptom improvement. Premature cessation may compromise treatment efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, edema, dyspnea) require prompt medical help. Prior to commencing treatment, inform your doctor of all current medications and pre-existing health conditions. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Junicef-S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Junicef-S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Junicef-S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Junicef-S 250mg/125mg Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
How Junicef-S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Junicef-S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this action by bolstering Ceftriaxone's effectiveness and overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Junicef-S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Junicef-S 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Junicef-S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Junicef-S 250mg/125mg Injection may induce drowsiness, blurred vision, or dizziness. Operating a vehicle should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Junicef-S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use the Junicef-S 250mg/125mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage changes for Junicef-S 250mg/125mg Injection are unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Junicef-S 250mg/125mg Injection :
Should you forget a scheduled dose of Junicef-S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Junicef-S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
